Skip Navigation

Details for High Impact Journal

Superfund Research Program

Movement Disorders (impact factor: 10.338)

2014

  • Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Swanson PD, Smith-Weller T, Racette BA, Checkoway H. 2014. Formulations of hormone therapy and risk of Parkinson's disease. Movement Disorders 29:1631-1636. doi:10.1002/mds.26037 PMID:25255692 PMCID:PMC4216612

2012

  • Mata IF, Checkoway H, Hutter CM, Samii A, Roberts JW, Kim H, Alvarez V, Ribacoba R, Pastor P, Lorenzo-Betancor O, Infante J, Sierra M, Gomez-Garre P, Mir P, Ritz B, Rhodes SL, Colcher A, Van Deerlin V, Chung KA, Quinn JF, Yearout D, Martizez E, Farin FM, Wan JY, Edwards KL, Zabetian CP. 2012. Common variation in the LRRK2 gene is a risk factor for Parkinson's disease. Movement Disorders 27(14):1823-1826. doi:10.1002/mds.25226 PMID:23115130 PMCID:PMC3536918
  • Mollenhauer B, Zhang J. 2012. Biochemical premotor biomarkers for Parkison's Disease. Movement Disorders 27:644-650. doi:10.1002/mds.24956 PMID:22508282 PMCID:PMC3428741
  • Nielsen SS, Gallagher LG, Lundin JI, Longstreth WT, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. 2012. Environmental tobacco smoke and Parkinson's disease. Movement Disorders 27(2):293-297. doi:10.1002/mds.24012 PMID:22095755 PMCID:PMC3289937

2011

  • Louis ED, Hafeman D, Parvez F, Liu X, Alcalay RN, Islam T, Ahmed A, Siddique A, Patwary T, Melkonian S, Argos M, Levy D, Ahsan H. 2011. Tremor severity and age: a cross-sectional, population-based study of 2,524 young and midlife normal adults. Movement Disorders 26:1515-1520. doi:10.1002/mds.23674 PMID:21442657

2010

  • Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. 2010. CSF AB42 and Tau in Parkinson's disease with cognitive impairment. Movement Disorders 25(15):2682-2685. doi:10.1002/mds.23287 PMID:20818673 PMCID:PMC2978754

2006

  • Hafeman D, Ahsan H, Islam T, Louis ED. 2006. Betel quid: Its tremor-producing effects in residents of Araihazar, Bangladesh. Movement Disorders 21(4):567-571. PMID:16250027
  • Ton TG, Heckbert SR, Longstreth WT, Rossing MA, KuKull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. 2006. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Movement Disorders 21(7):964-969. PMID:16550541

2004

  • Costa-Mallen P, Afsharinejad Z, Kelada SN, Costa LG, Franklin GM, Swanson PD, Longstreth WT, Viernes HA, Farin FM, Smith-Weller T, Checkoway H. 2004. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls. Movement Disorders 19(1):76-83. PMID:14743364

2001

  • Farin FM, Hitosis Y, Hallagan SE, Kushleika JV, Woods JS, Janssen P, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. 2001. Genetic polymorphisms of superoxide dismutase in Parkinson's disease. Movement Disorders 16(4):705-707. PMID:11481695

1999

  • Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. 1999. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Movement Disorders 14(1):21-27. PMID:9918340
Back
to Top
Last Reviewed: December 05, 2024